Latest Articles
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature
Published: Aug. 26, 2025, 11:43 a.m.
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor - connectedtoindia.com
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor connectedtoindia.com
Published: Aug. 26, 2025, 4:39 a.m.
Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation - Frontiers
Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation Frontiers
Published: Aug. 25, 2025, 10:47 a.m.
World-first therapy to target endometriosis and deadly cancer - Herald Sun
World-first therapy to target endometriosis and deadly cancer Herald Sun
Published: Aug. 24, 2025, noon
World-first therapy to target endometriosis and deadly cancer - The Mercury
World-first therapy to target endometriosis and deadly cancer The Mercury
Published: Aug. 23, 2025, 7:06 p.m.
World-first therapy to target endometriosis and deadly cancer - Gold Coast Bulletin
World-first therapy to target endometriosis and deadly cancer Gold Coast Bulletin
Published: Aug. 23, 2025, 7:02 p.m.
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer - Nature
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer Nature
Published: Aug. 18, 2025, 7:15 a.m.
Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy - Cureus
Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy Cureus
Published: Aug. 13, 2025, 1:15 p.m.
The effectiveness of stem cell‑derived extracellular vesicles therapy for intrauterine adhesions: a meta-analysis of preclinical studies - Reproductive Biology and Endocrinology
The effectiveness of stem cell‑derived extracellular vesicles therapy for intrauterine adhesions: a meta-analysis of preclinical studies Reproductive Biology and Endocrinology
Published: Aug. 13, 2025, 11:10 a.m.
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight - The Malaysian Reserve
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight The Malaysian Reserve
Published: Aug. 12, 2025, 10:20 p.m.
Link copied to clipboard!